2.67
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HUMA Giù?
Forum
Previsione
Precedente Chiudi:
$2.73
Aprire:
$2.695
Volume 24 ore:
4.05M
Relative Volume:
1.04
Capitalizzazione di mercato:
$414.17M
Reddito:
-
Utile/perdita netta:
$-110.78M
Rapporto P/E:
-2.4953
EPS:
-1.07
Flusso di cassa netto:
$-75.59M
1 W Prestazione:
+10.33%
1M Prestazione:
+19.73%
6M Prestazione:
-42.08%
1 anno Prestazione:
-66.87%
Humacyte Inc Stock (HUMA) Company Profile
Nome
Humacyte Inc
Settore
Industria
Telefono
919-313-9633
Indirizzo
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Confronta HUMA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
HUMA
Humacyte Inc
|
2.67 | 356.77M | 0 | -110.78M | -75.59M | -1.07 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-05-14 | Ripresa | H.C. Wainwright | Buy |
2024-12-20 | Reiterato | H.C. Wainwright | Buy |
2023-12-11 | Iniziato | H.C. Wainwright | Buy |
2023-08-14 | Aggiornamento | Piper Sandler | Underweight → Neutral |
2023-06-22 | Iniziato | Cantor Fitzgerald | Overweight |
2022-05-16 | Downgrade | Piper Sandler | Overweight → Underweight |
2021-10-29 | Iniziato | Cowen | Outperform |
2021-09-24 | Iniziato | Oppenheimer | Outperform |
2021-09-22 | Iniziato | BTIG Research | Buy |
2021-09-16 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Humacyte Inc Borsa (HUMA) Ultime notizie
Will Humacyte Inc. Equity Warrant stock benefit from AI tech trendsBreakout stock performance - jammulinksnews.com
Humacyte rises on Symvess sale to military treatment facility - MSN
What drives Humacyte Inc. Equity Warrant stock priceExplosive trading opportunities - Autocar Professional
Humacyte, Inc. shares rise 1.47% after-hours after announcing first Symvess sale to U.S. Military Treatment Facility. - AInvest
Humacyte Inc. Equity Warrant Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com
Humacyte shares climb 6% after first Symvess sale to U.S. military hospital - MSN
Is Humacyte Inc. Equity Warrant a good long term investmentUnprecedented profit potential - Autocar Professional
Humacyte stock rises after first Symvess sale to US Military facility - Investing.com India
Humacyte Announces First Symvess™ Sale to Military Treatment Facility - The Manila Times
Humacyte Breaks Into Military Healthcare: FDA-Approved Symvess Now Serving 200,000 Military Personnel - Stock Titan
What drives Humacyte Inc. stock priceFree Consultation - Autocar Professional
What analysts say about Humacyte Inc. stockMassive profits - jammulinksnews.com
Is Humacyte Inc. a good long term investmentOutstanding risk-reward balance - jammulinksnews.com
Humacyte Inc. Stock Analysis and ForecastFree Advanced Stock Screener Access - jammulinksnews.com
What analysts say about Humacyte Inc. Equity Warrant stockConsistently profitable trades - jammulinksnews.com
Humacyte, Inc. (HUMA) Dips More Than Broader Market: What You Should Know - MSN
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Humacyte, Inc.(HUMA) Shareholders - ACCESS Newswire
Humacyte outlines expansion of Symvess to 45 hospitals while targeting BLA submission for ATEV in dialysis by 2026 - MSN
Why Humacyte, Inc. (HUMA) Dipped More Than Broader Market Today - MSN
HUMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Humacyte, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Humacyte Inc Azioni (HUMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):